AbbVie Inc.ABBVNYSE
Loading
Year-over-year free cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | -35.06% |
| Q3 2025 | 54.14% |
| Q2 2025 | 248.86% |
| Q1 2025 | -79.28% |
| Q4 2024 | 29.99% |
| Q3 2024 | 156.06% |
| Q2 2024 | -47.23% |
| Q1 2024 | -15.41% |
| Q4 2023 | -38.16% |
| Q3 2023 | 19.77% |
| Q2 2023 | 52.84% |
| Q1 2023 | -44.31% |
| Q4 2022 | -2.83% |
| Q3 2022 | 52.71% |
| Q2 2022 | 2.44% |
| Q1 2022 | -2.91% |
| Q4 2021 | -36.67% |
| Q3 2021 | 64.39% |
| Q2 2021 | 0.13% |
| Q1 2021 | 2.49% |
| Q4 2020 | -18.49% |
| Q3 2020 | 92.75% |
| Q2 2020 | -21.08% |
| Q1 2020 | 18.57% |
| Q4 2019 | -29.29% |
| Q3 2019 | 87.36% |
| Q2 2019 | -19.28% |
| Q1 2019 | -10.98% |
| Q4 2018 | -22.94% |
| Q3 2018 | 54.14% |
| Q2 2018 | 8.95% |
| Q1 2018 | 5.16% |
| Q4 2017 | -23.62% |
| Q3 2017 | 67.55% |
| Q2 2017 | -6.48% |
| Q1 2017 | 40.64% |
| Q4 2016 | 6.41% |
| Q3 2016 | -24.96% |
| Q2 2016 | -10.96% |
| Q1 2016 | 10.40% |